Facebook Linkedin RSS Twitter Youtube
Home 2020

Regeneron

Moderna, Regeneron COVID-19 Candidates Show Early Positive Data
Coronavirus

Moderna, Regeneron COVID-19 Candidates Show Early Positive Data

Alex Philippidis -
0
Regeneron Advances Antibody Cocktail into Phase III Trials
Coronavirus

Regeneron Advances Antibody Cocktail into Phase III Trials

Alex Philippidis -
0
Eli Lilly, Junshi Biosciences, and Institute of Microbiology, Chinese Academy of Science – etesevimab (LY-CoV016 or JS016)
News

Eli Lilly, Junshi Biosciences, and Institute of Microbiology, Chinese Academy of Science – etesevimab (LY-CoV016 or JS016)

Alex Philippidis -
0
Regeneron Launches Trials of COVID-19 Antibody “Cocktail”
Coronavirus

Regeneron Launches Trials of COVID-19 Antibody “Cocktail”

Alex Philippidis -
0
Regeneron Pharmaceuticals and Roche – REGEN-COV™ / Ronapreve™ (casirivimab and imdevimab)
News

Regeneron Pharmaceuticals and Roche – REGEN-COV™ / Ronapreve™ (casirivimab and imdevimab)

Alex Philippidis -
0
COVID-19 Drug & Vaccine Candidate Tracker
Coronavirus

COVID-19 Drug & Vaccine Candidate Tracker

Alex Philippidis -
0
Regeneron Pharmaceuticals and Sanofi – Kevzara®
News

Regeneron Pharmaceuticals and Sanofi – Kevzara®

Alex Philippidis -
0
Sanofi, Regeneron Narrow Phase III Kevzara Trial to Critical COVID-19 Patients
Coronavirus

Sanofi, Regeneron Narrow Phase III Kevzara Trial to Critical COVID-19 Patients

Alex Philippidis -
0
Regeneron, Sanofi Launch Clinical Trial of Kevzara as Coronavirus Treatment
Coronavirus

Regeneron, Sanofi Launch Clinical Trial of Kevzara as Coronavirus Treatment

Alex Philippidis -
0
Top 15 Best-Selling Drugs of 2019
A-Lists

Top 15 Best-Selling Drugs of 2019

Alex Philippidis -
0
1234...11Page 3 of 11
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.